GB9201755D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB9201755D0 GB9201755D0 GB929201755A GB9201755A GB9201755D0 GB 9201755 D0 GB9201755 D0 GB 9201755D0 GB 929201755 A GB929201755 A GB 929201755A GB 9201755 A GB9201755 A GB 9201755A GB 9201755 D0 GB9201755 D0 GB 9201755D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201755A GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
| AU33639/93A AU3363993A (en) | 1992-01-28 | 1993-01-27 | Amino acid derivatives as PAF antagonists |
| PCT/GB1993/000167 WO1993015047A1 (en) | 1992-01-28 | 1993-01-27 | Amino acid derivatives as paf antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201755A GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9201755D0 true GB9201755D0 (en) | 1992-03-11 |
Family
ID=10709355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929201755A Pending GB9201755D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU3363993A (en) |
| GB (1) | GB9201755D0 (en) |
| WO (1) | WO1993015047A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| US10640563B2 (en) | 2016-06-08 | 2020-05-05 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4327256A1 (en) * | 1993-08-13 | 1995-02-16 | Bayer Ag | Sulfonylbenzyl-substituted benzimidazoles, process for their preparation and their use in medicaments |
| US5824696A (en) * | 1993-09-01 | 1998-10-20 | Smithkline Beecham Corporation | Medicaments |
| US5756548A (en) * | 1995-04-03 | 1998-05-26 | Centaur Pharmaceuticals, Inc. | Acetamidobenzamide compounds for neurodegenerative disorders |
| US5955506A (en) * | 1996-04-03 | 1999-09-21 | Centaur Pharmaceuticals, Inc. | Benzamides for neurodegenerative disorder treatment |
| ATE320249T1 (en) | 1997-07-08 | 2006-04-15 | Ono Pharmaceutical Co | AMINO ACID DERIVATIVES |
| TWI245035B (en) | 1998-06-26 | 2005-12-11 | Ono Pharmaceutical Co | Amino acid derivatives and a pharmaceutical composition comprising the derivatives |
| EP1097929A4 (en) | 1998-07-14 | 2005-12-21 | Ono Pharmaceutical Co | Amino acid derivatives and drugs containing the same as the active ingredient |
| SE0000382D0 (en) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
| JP2005506949A (en) | 2000-12-20 | 2005-03-10 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | Diamines as modulators of chemokine receptors |
| CA2432369A1 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
| EP1357908A4 (en) | 2001-01-30 | 2009-07-15 | Merck & Co Inc | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| RS51097B (en) | 2002-03-26 | 2010-10-31 | Boehringer Ingelheim Pharmaceuticals Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions,and uses thereof |
| US7037936B2 (en) | 2002-06-17 | 2006-05-02 | Signal Pharmaceuticals, Llc. | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| TW200510305A (en) | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| UY28526A1 (en) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME |
| US7291744B2 (en) | 2003-11-13 | 2007-11-06 | Bristol-Myers Squibb Company | N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
| US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| EP1809622B1 (en) | 2004-09-22 | 2010-07-21 | Janssen Pharmaceutica N.V. | Inhibitors of the interaction between mdm2 and p53 |
| PE20060776A1 (en) | 2004-12-27 | 2006-09-26 | Boehringer Ingelheim Pharma | MIMETICS OF GLUCOCORTICOIDES, METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS |
| KR20090097908A (en) | 2006-12-06 | 2009-09-16 | 베링거 인겔하임 인터내셔날 게엠베하 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| UY30892A1 (en) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | AKT ACTIVITY INHIBITORS |
| NZ583350A (en) * | 2007-08-21 | 2012-03-30 | Senomyx Inc | Heteroaryl-hydantoin derivatives as bitter taste inhibitors |
| CN102112476A (en) | 2008-06-06 | 2011-06-29 | 贝林格尔.英格海姆国际有限公司 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| JP7337174B2 (en) | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Trisubstituted Heteroaryl Derivatives as Src Homology-2 Phosphatase Inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904174D0 (en) * | 1989-02-23 | 1989-04-05 | British Bio Technology | Compounds |
| PT98674B (en) * | 1990-08-15 | 1999-01-29 | British Bio Technology | METHOD FOR THE PREPARATION OF COMPOUNDS THAT ARE ANTAGONISTS OF THE ACTIVATION FACTOR OF PLATELETS FOR EXAMPLE DERIVATIVES OF IMIDAZOLE AND OF THEIR INTERMEDIARIES |
| PT98673B (en) * | 1990-08-15 | 1999-01-29 | British Bio Technology | METHOD FOR PREPARING COMPOUNDS THAT ARE ANTAGONISTS OF THE ACTIVATION FACTOR OF PLATELETS FOR EXAMPLE DERIVATIVES OF BENZIMIDAZOLE AND THEIR INTERMEDIARIES |
| GB9107398D0 (en) * | 1991-04-09 | 1991-05-22 | British Bio Technology | Compounds |
-
1992
- 1992-01-28 GB GB929201755A patent/GB9201755D0/en active Pending
-
1993
- 1993-01-27 AU AU33639/93A patent/AU3363993A/en not_active Abandoned
- 1993-01-27 WO PCT/GB1993/000167 patent/WO1993015047A1/en active Application Filing
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680239B2 (en) | 2000-12-22 | 2014-03-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Use of RGM and its modulators |
| US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
| US9175075B2 (en) | 2009-12-08 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein |
| EP3916103A1 (en) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| US10640563B2 (en) | 2016-06-08 | 2020-05-05 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| US11759527B2 (en) | 2021-01-20 | 2023-09-19 | Abbvie Inc. | Anti-EGFR antibody-drug conjugates |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3363993A (en) | 1993-09-01 |
| WO1993015047A1 (en) | 1993-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300508A0 (en) | Compounds | |
| GB9209628D0 (en) | Compounds | |
| GB9200245D0 (en) | Compounds | |
| GB9201755D0 (en) | Compounds | |
| GB9200210D0 (en) | Compounds | |
| GB9201693D0 (en) | Compounds | |
| GB9200209D0 (en) | Compounds | |
| GB9210632D0 (en) | Compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9201692D0 (en) | Compounds | |
| GB9205859D0 (en) | Compounds | |
| GB9201745D0 (en) | Compounds | |
| GB9207759D0 (en) | Compounds | |
| GB9203172D0 (en) | Compounds | |
| GB9202991D0 (en) | Compounds | |
| GB9202827D0 (en) | Compounds | |
| GB9203171D0 (en) | Compounds | |
| GB9203174D0 (en) | Compounds | |
| GB9203173D0 (en) | Compounds | |
| GB9203175D0 (en) | Compounds | |
| GB9210633D0 (en) | Compounds | |
| GB9201744D0 (en) | Compounds | |
| GB9203170D0 (en) | Compounds |